Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2007American Journal of Nephrology

Effects of Pyridoxamine in Combined Phase 2 Studies of Patients with Type 1 and Type 2 Diabetes and Overt Nephropathy

View Full Paper
Ask AI
Bookmark
Share

Authors

MWMark E. WilliamsDuPont (United States)WBW. Kline BoltonUniversity of VirginiaRKRaja G. KhalifahFamily Health International 360

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Williams et al. (2007) studied this question.

synapsesocial.com/papers/69dff8f7ca6b6a2615860922https://doi.org/10.1159/000108104
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched one closely related paper. Consider it for comparative context:

  1. 1Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes2001 · 6,044 citations